Viewing StudyNCT06453668



Ignite Creation Date: 2024-06-16 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06453668
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-12
First Post: 2024-05-06

Brief Title: A Study of TCD601 Siplizumab in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis ALS Patients
Sponsor: ITB-Med LLC
Organization: ITB-Med LLC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-04-16
Start Date Type: ACTUAL
Primary Completion Date: 2026-11
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-11
Completion Date Type: ESTIMATED
First Submit Date: 2024-05-06
First Submit QC Date: June 10 2024
Study First Post Date: 2024-06-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-09
Last Update Post Date: 2024-06-12
Last Update Post Date Type: ACTUAL